Sep 22, 2026 · 6 min
Kingfisher lifts guidance as Ericsson loses analyst support
Kingfisher Soars, Roche's Shot, Ericsson's Slip
The episode contrasts a retailer gaining momentum from operational growth with a telecom equipment maker facing margin and demand concerns.
- 1Kingfisher raised full-year guidance after stronger first-half results, led by Screwfix, international operations, and e-commerce.
- 2Morgan Stanley downgraded Ericsson to underweight, citing weakening margins, limited revenue growth, and softer North American demand.
- 3Roche’s promising mid-stage obesity-treatment results add a healthcare catalyst to the day’s market-moving developments.
Don't miss
Kingfisher’s upgraded guidance, supported by Screwfix, international operations, and e-commerce, provides the episode’s strongest positive market signal.
The brief
Bloomberg’s Stock Movers Report brings together Caroline Hepburn, Lizzie Burden, and Louise Moon to examine the companies moving European markets.
Kingfisher raised its full-year guidance after stronger-than-expected first-half results, with Screwfix, Poland, Spain, and e-commerce offsetting relatively flat B&Q sales.
Ericsson moved in the opposite direction after Morgan Stanley downgraded it to underweight, pointing to weakening margins, limited growth, and softer North American demand.
The episode’s central contrast is operational momentum versus deteriorating expectations: Kingfisher benefits from several growth engines, while Ericsson loses analyst confidence.
Roche’s promising mid-stage obesity-treatment results round out the briefing, adding a healthcare development to the retail and telecom moves.
What was said on this episode
5 statements · 3 positive · 2 negative
Kingfisher raised full-year guidance beyond expectations
“it's lifted its full-year guidance beyond expectations”
Listen at 0:58
Kingfisher’s first-half earnings beat estimates
“their first half earnings. Those beat estimates”
Listen at 1:05
Roche’s highest-dose obesity shot reduced average body weight 15.5%
“those who received the highest dose lost an average of 15.5% of their body weight in that trial”
Listen at 2:40
Morgan Stanley downgraded Ericsson to underweight
“Morgan Stanley this morning have downgraded it to underweight from equal weight”
Listen at 3:11
Anticipated 5G network spending failed to materialize
“There was anticipated spending on 5G networks that failed to materialize”
Listen at 3:42
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Mentioned
Kingfisher
Screwfix
B&Q
PolandListen to the full episode and explore every guest, topic, and moment on PodLume.